Bay Biosciences provides ethically sourced serum and plasma samples from Inflammatory Bowel Disease (IBD) patients through both prospective and retrospective biospecimen collection models. Our clinically annotated biofluids support biomarker discovery, translational research, and drug development, helping biotech and pharmaceutical companies advance research in Crohn’s disease and ulcerative colitis. Learn more about our available IBD biospecimens to support your research.
Liens sociaux
Rechercher
Mises à jour récentes
Plus de lecture